"The public market has increased its size incredibly with 50 percent growth last year as a consequence of the implementation of JKN back in 2014."
In Conversation
"As the Director of the Pharmaceutical Chamber, the main message I’m conveying to the government is that they need to minimize changes in the regulations in…
"Private hospitals represent more than 50 percent of the hospitals in the country and, consequently, their inclusion in the governmental healthcare policies is crucial to ensure…
"What matters most to AFIDRO and every stakeholder is that the regulation is applied in a systemic, predictable way."
"We wish to bring the concept of integrity closer to the ones in charge of creating regulation and have them realize that the pharmaceutical industry is…
"Teva’s market position moved from the twelfth to the fifth rank between 2013 and 2017 in Ukraine, and Teva is now the largest international company operating…
"The main issue at the moment is about bringing more health education to the population because when we look at the top ten illnesses in our…
"[INVIMA's] four priorities include increasing institutional strengthening, improving efficiency, ensuring transparency and fostering the institution and country's competitiveness."
"In 2012, we decided to open a representative office in Indonesia because of the high dynamism of the national regulatory environment as well as our corporate…
"The Colombian affiliate has significantly changed in the last four years and has become an operational center for the Andean region"
"Our innovative cancer medicine gives physicians a new therapeutic option and hope in managing the tens of thousands of lung cancer patients across the country."
"In order to succeed, pharmaceutical players have to introduce medicines that fulfill the local healthcare needs and create healthcare breakthroughs in Indonesia"
